Health Care
Eli Lilly to collaborate with AC Immune for the treatment of Alzheimer’s disease
Eli Lilly (NYSE: LLY) partners with Switzerland-based AC Immune (Nasdaq: ACIU) to research and develop the potential treatment for Alzheimer's…
Arrowhead Pharmaceuticals reports a loss of 12 cents per share in Q4
Arrowhead Pharmaceuticals (ARWR) reported Q4 and fiscal 2018 earnings results after the bell today. For the fourth quarter ended September 30,…
Merck announces management changes
Merck (MRK) announced that Adam Schechter, President of Global Human Health (GHH) division will step down from his present role…
Pfizer pares recent gains after JP Morgan slashes rating
The outlook for Pfizer (PFE) remains mixed as the drug maker gears up for a closely-followed leadership change early next…
Avid Bioservices Q2 loss narrows despite lower revenues; reaffirms outlook
Avid Bioservices (CDMO) reported a narrower net loss for the second quarter of 2019, helped by a sharp decline in…
Tivity Health set to redefine fitness market with Nutrisystem acquisition
The fitness industry has witnessed a lot of innovation in recent times as companies strive to cash in on the…
Marinus Pharmaceuticals (MRNS) surges on positive data from Ganaxolone trial
Shares of Marinus Pharmaceuticals (MRNS) jumped after the pharma company reported positive data from the Phase 2 ganaxolone clinical trial in…
Gilead names Daniel O’Day as Chairman and CEO
Gilead Sciences Inc. (GILD) has named Daniel O’Day as its new Chairman and Chief Executive Officer, effective March 1, 2019.…
Earnings Preview: Q2 results may set the tone for Avid Bioservices’ recovery
Avid Bioservices (CDMO), a contract manufacturer in the biotechnology industry, is scheduled to release its second-quarter financial results Monday after…
Moderna raises over $600-million through IPO, falls below IPO price
Biotech company Moderna raised above $600 million on Thursday by selling about 26 million of its common stock at $23…